Dr. Robert Lin Li, MD, PhD

Dr. Li practices at Madison Park Surgery & Laser Center in Torrance, California.

Dr. Li's NPI, 1902241607, was assigned on May 8, 2013. Dr. Li graduated from UT Southwestern Medical Center in 2013. Dr. Li's California license number on file is A142061.

Dr. Li's primary practice is Madison Park Surgery & Laser Center, at 3445 Pacific Coast Hwy, Torrance, CA 90505 in Los Angeles County. The practice phone is (310) 530-2900.

Dr. Li's primary practice is Madison Park Surgery & Laser Center in Torrance, California. Dr. Li is also affiliated with Torrance Memorial Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Li to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 6 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Li is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Li's licenses on file in 2 states: California and Illinois.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, hypercalcemia, osteoporosis, overactive thyroid and parathyroid gland disorder among the conditions Dr. Li treats.

CMS data shows 7,310 Medicare services from Dr. Li across 12 procedure codes in 2024, for 725 Medicare patients. Medicare paid $269,995 for them.

CMS counts 725 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 331 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 58, with 66% women.

In 2024, Dr. Li wrote 4,633 Medicare Part D claims for 780 patients. 47% of them were for generic drugs. CMS names the drug for 4,274 of them, across 60 drugs with 11 or more claims each, at $2,011,570 in total drug cost. In 2023, CMS named 3,538 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Li for performance year 2024, reported as part of a group. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Li as offering telehealth.

Dmand AI links 6 papers to Dr. Li, published from 2010 to 2012. 2010 was the busiest year, with 2. The most frequent topics are Adipose Tissue, Caloric Restriction and Ghrelin. Dr. Li's most frequent co-authors are Joseph Leonard Goldstein, MD, Michael Brown, MD and Benjamin Lawrence Elsbernd, MD.

CMS Open Payments shows 96 general payments to Dr. Li from 5 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Eli Lilly and Company paid the most, $38,606.

Dr. Li graduated from UT Southwestern Medical Center in 2013.

Dr. Li is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.